150 related articles for article (PubMed ID: 10994564)
1. [Cost stratification of nonsteroidal anti-inflammatory drug-associated gastrointestinal side effects].
Lanas A
Med Clin (Barc); 2000; 114 Suppl 3():46-53. PubMed ID: 10994564
[TBL] [Abstract][Full Text] [Related]
2. [Severe gastrointestinal complications potentially associated with the use of non-steroidal anti-inflammatory agents: hospital treatment costs for the National Health System of our country].
Vargas E; Cabrera L; Morón A; García M; Soto J; Rejas J
An Med Interna; 2001 Nov; 18(11):564-8. PubMed ID: 11862765
[TBL] [Abstract][Full Text] [Related]
3. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use.
Lanas A; Perez-Aisa MA; Feu F; Ponce J; Saperas E; Santolaria S; Rodrigo L; Balanzo J; Bajador E; Almela P; Navarro JM; Carballo F; Castro M; Quintero E;
Am J Gastroenterol; 2005 Aug; 100(8):1685-93. PubMed ID: 16086703
[TBL] [Abstract][Full Text] [Related]
4. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland.
Delcò F; Michetti P; Beglinger C; Fried M; Szucs TD
Digestion; 2004; 69(1):10-9. PubMed ID: 14755148
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug usage and gastrointestinal outcomes in the Republic of Serbia.
Petric M; Tasic L; Sukljevic S
J Pain Palliat Care Pharmacother; 2009; 23(1):40-7. PubMed ID: 19296354
[TBL] [Abstract][Full Text] [Related]
6. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.
Spiegel BM; Chiou CF; Ofman JJ
Arthritis Rheum; 2005 Apr; 53(2):185-97. PubMed ID: 15818647
[TBL] [Abstract][Full Text] [Related]
7. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients.
Solomon DH; Glynn RJ; Bohn R; Levin R; Avorn J
J Rheumatol; 2003 Apr; 30(4):792-8. PubMed ID: 12672201
[TBL] [Abstract][Full Text] [Related]
8. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib.
Steinfeld S; Bjørke PA
Rheumatology (Oxford); 2002 Apr; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277
[TBL] [Abstract][Full Text] [Related]
9. Utilization and cost comparison of current and optimal prescribing of nonsteroidal antiinflammatory drugs in Quebec, Canada.
Rahme E; Toubouti Y; Lelorier J
J Rheumatol; 2006 Mar; 33(3):588-96. PubMed ID: 16463432
[TBL] [Abstract][Full Text] [Related]
10. Association of nonsteroidal antiinflammatory drugs with upper gastrointestinal disease: epidemiologic and economic considerations.
Hochberg MC
J Rheumatol Suppl; 1992 Nov; 36():63-7. PubMed ID: 1474537
[TBL] [Abstract][Full Text] [Related]
11. Economic analysis of strategies in the prevention of non-steroidal anti-inflammatory drug-induced complications in the gastrointestinal tract.
Lanas A
Aliment Pharmacol Ther; 2004 Aug; 20(3):321-31. PubMed ID: 15274669
[TBL] [Abstract][Full Text] [Related]
12. Cost-efficiency of nonsteroidal anti-inflammatory drug prescribing in Zagreb, Croatia.
Vukusić I; Stimac D; Culig J
Coll Antropol; 2005 Jun; 29(1):143-7. PubMed ID: 16117313
[TBL] [Abstract][Full Text] [Related]
13. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.
Murthy SK; Kauldher S; Targownik LE
Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943
[TBL] [Abstract][Full Text] [Related]
14. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
15. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs.
Bloom BS
Arch Intern Med; 1989 May; 149(5):1019-22. PubMed ID: 2719496
[TBL] [Abstract][Full Text] [Related]
16. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
Rahme E; Pettitt D; LeLorier J
Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
[TBL] [Abstract][Full Text] [Related]
17. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of NSAID induced gastrointestinal complications.
Singh G; Triadafilopoulos G
J Rheumatol Suppl; 1999 Apr; 56():18-24. PubMed ID: 10225536
[TBL] [Abstract][Full Text] [Related]
19. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms.
Thomas J; Straus WL; Bloom BS
Am J Gastroenterol; 2002 Sep; 97(9):2215-9. PubMed ID: 12358235
[TBL] [Abstract][Full Text] [Related]
20. Assessment of hospital costs related to the diagnosis and treatment of upper gastrointestinal haemorrhages in patients consuming non steroid anti-inflammatory drugs.
Vargas E; Cabrera L; Morón A; García M; Soto J; Guadarrama I
Rev Esp Enferm Dig; 2001 Jun; 93(6):390-7. PubMed ID: 11482042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
